These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16401852)

  • 1. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
    Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS.
    Scelsa SN; MacGowan DJ; Mitsumoto H; Imperato T; LeValley AJ; Liu MH; DelBene M; Kim MY
    Neurology; 2005 Apr; 64(7):1298-300. PubMed ID: 15824372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.
    Meininger V; Drory VE; Leigh PN; Ludolph A; Robberecht W; Silani V
    Amyotroph Lateral Scler; 2009; 10(5-6):378-83. PubMed ID: 19922128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
    Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials.
    Meininger V; Bensimon G; Bradley WR; Brooks B; Douillet P; Eisen AA; Lacomblez L; Leigh PN; Robberecht W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):107-17. PubMed ID: 15204012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II/III randomized trial of TCH346 in patients with ALS.
    Miller R; Bradley W; Cudkowicz M; Hubble J; Meininger V; Mitsumoto H; Moore D; Pohlmann H; Sauer D; Silani V; Strong M; Swash M; Vernotica E;
    Neurology; 2007 Aug; 69(8):776-84. PubMed ID: 17709710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety of riluzole in amyotrophic lateral sclerosis.
    Lacomblez L; Bensimon G; Leigh PN; Debove C; Bejuit R; Truffinet P; Meininger V;
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):23-9. PubMed ID: 12061945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized sequential trial of creatine in amyotrophic lateral sclerosis.
    Groeneveld GJ; Veldink JH; van der Tweel I; Kalmijn S; Beijer C; de Visser M; Wokke JH; Franssen H; van den Berg LH
    Ann Neurol; 2003 Apr; 53(4):437-45. PubMed ID: 12666111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
    Lacomblez L; Bensimon G; Leigh PN; Guillet P; Meininger V
    Lancet; 1996 May; 347(9013):1425-31. PubMed ID: 8676624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group.
    Miller RG; Petajan JH; Bryan WW; Armon C; Barohn RJ; Goodpasture JC; Hoagland RJ; Parry GJ; Ross MA; Stromatt SC
    Ann Neurol; 1996 Feb; 39(2):256-60. PubMed ID: 8967757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis.
    Lenglet T; Lacomblez L; Abitbol JL; Ludolph A; Mora JS; Robberecht W; Shaw PJ; Pruss RM; Cuvier V; Meininger V;
    Eur J Neurol; 2014 Mar; 21(3):529-36. PubMed ID: 24447620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of celecoxib in amyotrophic lateral sclerosis.
    Cudkowicz ME; Shefner JM; Schoenfeld DA; Zhang H; Andreasson KI; Rothstein JD; Drachman DB
    Ann Neurol; 2006 Jul; 60(1):22-31. PubMed ID: 16802291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis.
    de Carvalho M; Pinto S; Costa J; Evangelista T; Ohana B; Pinto A
    Amyotroph Lateral Scler; 2010 Oct; 11(5):456-60. PubMed ID: 20565333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB; Dubois B; de Yébenes JG; Kremer B; Gaus W; Kraus PH; Przuntek H; Dib M; Doble A; Fischer W; Ludolph AC;
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.